Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial
2016 ◽
Vol 23
(3)
◽
pp. 167-173
◽